Article
Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma
11 Sept 2015
Abstract excerpt
BACKGROUND: It is well-known that the treatment and monitoring methods are limited for advanced stage of endometrial carcinoma. Biological molecules with expression changes during tumor progression become potential therapeutic targets for advanced stage endometrial carcinoma. Annexin A2 (ANXA2) has been reported to be overexpressed in recurrent endometrial carcinoma, and the expression of human epididymis protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
